Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • News Analysis: Critical Shifts in Rakhine Politics

    News Analysis: Critical Shifts in Rakhine Politics
    In early 2016, the Arakan National Party expelled six senior members for opposing its party nominee for Rakhine State's chief minister, but the dust seemed to have settled until the deputy speaker U Phoe Min died of gastric cancer on June 17. The vacant position looked destined to be filled by the ANP-which won 23 of the 47 state parliament seats-but by exactly whom became the source of tense competition, resulting in party rifts and the dismissal of the victor. On July 13, the ANP steering committee listed criteria for possible candidates: a central executive committee member with a "reasonable" level of education who was faithful to the party and would follow its policies.
  • AstraZeneca revenue down as key drugs lose patent protection

    AstraZeneca revenue down as key drugs lose patent protection
    Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Total revenue declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent to $560 million.
  • Varian Medical Systems (VAR) Given Daily News Sentiment Rating of 0.31

    Varian Medical Systems (VAR) Given Daily News Sentiment Rating of 0.31
    Media stories about Varian Medical Systems have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources.
  • Upper Hutt man Jarred Townsend rushes to finish bucket list after being given weeks to live

    Upper Hutt man Jarred Townsend rushes to finish bucket list after being given weeks to live
    On the go and no time to finish that story right now? Your News is the place for you to save content to read later from any device. Register with us and content you save will appear here so you can access them to read later.
  • AstraZeneca shares plunge 15% as lung cancer study fails

    AstraZeneca shares plunge 15% as lung cancer study fails
    AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, sending its shares plunging on Thursday. The so-called MYSTIC study was the most anticipated clinical experiment in the pharmaceutical industry this year and the news saw the shares tumble 15 percent in early trade, putting them on track for their worst day ever.
  • Biocompare Cancer
  • Tilted Acoustic Tweezers Separate Cells Gently

    Tilted Acoustic Tweezers Separate Cells Gently
    Precise, gentle and efficient cell separation from a device the size of a cell phone may be possible thanks to tilt-angle standing surface acoustic waves, according to a team of engineers.
  • New Biomarker Highly Promising For Predicting Breast Cancer Outcomes

    New Biomarker Highly Promising For Predicting Breast Cancer Outcomes
    A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
  • Finding Keys To Glioblastoma Therapeutic Resistance

    Finding Keys To Glioblastoma Therapeutic Resistance
    Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
  • Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs

    Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs
    A revolutionary new scientific method developed at the University of Leeds will improve the diversity of 'biologically active molecules', such as antibiotics and anti-cancer agents.
  • Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma

    Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma
    CINCINNATI - An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.